Why the study?
The impact of transcatheter aortic valve replacement leaflet design on long-term device performance is still unknown.
Does intra-annular TAVR leaflet design compared to supra-annular design affect long-term survival and hemodynamic performance in patients with severe symptomatic aortic stenosis?
Does intra-annular TAVR leaflet design compared to supra-annular design affect long-term survival and hemodynamic performance in patients with severe symptomatic aortic stenosis?
Answers are grounded in this paper and cite their sources.
Intra-annular TAVR devices have similar 10-year survival compared to supra-annular devices but are associated with higher rates of bioprosthetic valve failure and hemodynamic deterioration, particularly in smaller valve sizes.
Background The impact of transcatheter aortic valve replacement (TAVR) leaflet design on long-term device performance is still unknown. This study sought to compare the clinical and hemodynamic outcomes of intra- (IA) versus supra-annular (SA) TAVR designs up-to 10-years following implantation. Methods Consecutive patients with at least 5-years follow-up following TAVR for severe symptomatic aortic stenosis from June 2007 to December 2016 were included. Bioprosthetic valve failure (BVF) and hemodynamic valve deterioration (HVD) were defined according to VARC-3 updated definitions and estimated using cumulative incidence function to account for the competing risk of death. Results A total of 604 patients (82 years; 53% female) were analyzed and divided into IA (482) and SA (122) groups. Overall survival rates at 10-years were similar (IA 15%, 95%CI: 10–22; SA 11%, 95%CI: 6–20; p = 0.21). Compared to the SA TAVR, mean transaortic gradients were significantly higher and increased over time in the IA group. IA TAVRs showed higher 10-year cumulative incidences of BVF (IA 8% vs. SA 1%, p = 0.02) and severe HVD (IA 5% vs. SA 1%, p = 0.05). The occurrence of BVF and HVD in the IA group occurred primarily in the smallest TAVR devices (20–23-mm). After excluding these sizes, the cumulative incidences of BVF (IA 5% vs. SA 1%, p = 0.40) and severe HVD (IA 2% vs. SA 1%, p = 0.11) were similar. Conclusion In this study, TAVR leaflet design had no impact on survival at 10-years. IA devices showed higher transaortic gradients and cumulative incidences of HVD and BVF predominantly occurring in the smallest valve sizes.
No takes yet. Share an insight, caveat, or question.
Scotti et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: